These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 18356349

  • 1. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis.
    Peacock WF, Hollander JE, Diercks DB, Lopatin M, Fonarow G, Emerman CL.
    Emerg Med J; 2008 Apr; 25(4):205-9. PubMed ID: 18356349
    [Abstract] [Full Text] [Related]

  • 2. Noninvasive ventilation outcomes in 2,430 acute decompensated heart failure patients: an ADHERE Registry Analysis.
    Tallman TA, Peacock WF, Emerman CL, Lopatin M, Blicker JZ, Weber J, Yancy CW, ADHERE Registry.
    Acad Emerg Med; 2008 Apr; 15(4):355-62. PubMed ID: 18370990
    [Abstract] [Full Text] [Related]

  • 3. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J, ADHERE Scientific Advisory Committee and Investigators, ADHERE Study Group.
    J Am Coll Cardiol; 2005 Jul 05; 46(1):57-64. PubMed ID: 15992636
    [Abstract] [Full Text] [Related]

  • 4. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR, Johannes RS, Pine M, Gupta V, Saltzberg M, Hay J, Yancy CW, Fonarow GC.
    Am Heart J; 2007 Aug 05; 154(2):267-77. PubMed ID: 17643575
    [Abstract] [Full Text] [Related]

  • 5. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS, Peacock WF, McMullin N, Jessie R, Fonarow GC, Wynne J, Mills RM.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):534-40. PubMed ID: 18687247
    [Abstract] [Full Text] [Related]

  • 6. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
    Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, ADHERE Scientific Advisory Committee and Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):76-84. PubMed ID: 16386668
    [Abstract] [Full Text] [Related]

  • 7. Venous thromboembolism prophylaxis in hospitalized heart failure patients.
    Jois-Bilowich P, Michota F, Bartholomew JR, Glauser J, Diercks D, Weber J, Fonarow GC, Emerman CL, Peacock WF, Adhere Scientific Advisory Committee and Investigators.
    J Card Fail; 2008 Mar 03; 14(2):127-32. PubMed ID: 18325459
    [Abstract] [Full Text] [Related]

  • 8. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease.
    Singer AJ, Emerman C, Char DM, Heywood JT, Kirk JD, Hollander JE, Summers R, Lee CC, Wynne J, Kellerman L, Peacock WF.
    Ann Emerg Med; 2008 Jan 03; 51(1):25-34. PubMed ID: 17949853
    [Abstract] [Full Text] [Related]

  • 9. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Galvao M, Kalman J, DeMarco T, Fonarow GC, Galvin C, Ghali JK, Moskowitz RM.
    J Card Fail; 2006 Mar 03; 12(2):100-7. PubMed ID: 16520256
    [Abstract] [Full Text] [Related]

  • 10. Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes.
    Iakobishvili Z, Cohen E, Garty M, Behar S, Shotan A, Sandach A, Gottlieb S, Mager A, Battler A, Hasdai D, Heart Failure Survey in Isarel (HFSIS) Investigators.
    Acute Card Care; 2011 Jun 03; 13(2):76-80. PubMed ID: 21627393
    [Abstract] [Full Text] [Related]

  • 11. Cardiac troponin and outcome in acute heart failure.
    Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AH, ADHERE Investigators.
    N Engl J Med; 2008 May 15; 358(20):2117-26. PubMed ID: 18480204
    [Abstract] [Full Text] [Related]

  • 12. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.
    Pharmacotherapy; 2006 Aug 15; 26(8):1078-85. PubMed ID: 16863484
    [Abstract] [Full Text] [Related]

  • 13. Impact of treatment guidelines on clinical and economic outcomes of acute decompensated heart failure.
    Didomenico RJ, Perez A, Schumann HM, Fontana DR, Kondos GT, Schumock GT.
    Ann Pharmacother; 2008 Mar 15; 42(3):327-33. PubMed ID: 18303142
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care.
    Hauptman PJ, Goodlin SJ, Lopatin M, Costanzo MR, Fonarow GC, Yancy CW.
    Arch Intern Med; 2007 Oct 08; 167(18):1990-7. PubMed ID: 17923600
    [Abstract] [Full Text] [Related]

  • 15. Do medications affect vital signs in the prehospital treatment of acute decompensated heart failure?
    Sporer KA, Tabas JA, Tam RK, Sellers KL, Rosenson J, Barton CW, Pletcher MJ.
    Prehosp Emerg Care; 2006 Oct 08; 10(1):41-5. PubMed ID: 16418090
    [Abstract] [Full Text] [Related]

  • 16. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
    Small RS, Wickemeyer W, Germany R, Hoppe B, Andrulli J, Brady PA, Labeau M, Koehler J, Sarkar S, Hettrick DA, Tang WH.
    J Card Fail; 2009 Aug 08; 15(6):475-81. PubMed ID: 19643357
    [Abstract] [Full Text] [Related]

  • 17. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure.
    Fonarow GC, ADHERE Scientific Advisory Committee.
    Rev Cardiovasc Med; 2003 Aug 08; 4 Suppl 7():S21-30. PubMed ID: 14668697
    [Abstract] [Full Text] [Related]

  • 18. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
    Prescrire Int; 2011 Jun 08; 20(117):156-60. PubMed ID: 21678708
    [Abstract] [Full Text] [Related]

  • 19. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE.
    Peacock WF, Fonarow GC, Emerman CL, Mills RM, Wynne J, ADHERE Scientific Advisory Committee and Investigators, Adhere Study Group.
    Cardiology; 2007 Jun 08; 107(1):44-51. PubMed ID: 16741357
    [Abstract] [Full Text] [Related]

  • 20. Acute kidney injury criteria predict outcomes of critically ill patients.
    Barrantes F, Tian J, Vazquez R, Amoateng-Adjepong Y, Manthous CA.
    Crit Care Med; 2008 May 08; 36(5):1397-403. PubMed ID: 18434915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.